Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01533480 · ClinicalTrials.gov registry record · Phase 4
A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
A Phase 4 study of Keratoconjunctivitis Due to Adenovirus and Viral Shedding, sponsored by Lifelong Vision Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01533480 is a Phase 4 study of Keratoconjunctivitis Due to Adenovirus and Viral Shedding that has completed, run by Lifelong Vision Foundation. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01533480, a Phase 4 study of Keratoconjunctivitis Due to Adenovirus and Viral Shedding, has completed, sponsored by Lifelong Vision Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are conducting this study because the patient have an eye infection which is called adenoviral conjunctivitis, and is the most common cause of "pink eye". There is currently no treatment for this condition. However, the researchers associated with this study want to understand if using a product called Zirgan, which is a topical ointment that is already FDA-approved for other types of eye infections, will help with the type of infection that the patient currently have. Zirgan is not FDA-approved to treat your type of eye infection. Your participation in this study is expected to last 21 days but the patient will only apply the topical ointment for 14 of those days. During the study, the patient will be asked to come into this clinic 8 times. The purpose of this study is to determine whether topical Zirgan can reduce days that the patient suffers from the eye infection, and also to see if it can prevent the infection from spreading to your second eye and to also see if it can prevent the spreading of the infection to people that the patient come in close contact with. Zirgan will be compared to Genteal Gel in this trial. Genteal Gel is a non-prescription eye lubricant gel and is commonly used for treatment of dry eye. The patient will be asked to apply a topical ointment (either Zirgan or Genteal gel 5 times a day for the first 7 days and then 3 times a day for the following 7 days. The patient will be asked to return to the clinic 21 days after the patient starts the study for a final check-up. It is planned that about 80 people with Adenovirus Conjunctivitis will be enrolled in this study between 8-12 sites across the United States. The patient will be assigned to either Zirgan or Genteal gel by chance which is similar to flipping a coin. The study groups will be assigned in a 1:1 ratio. Neither the patient nor the study doctor or study staff will be able to pick which study group The patient is in. The patient will not know and the study do
Conditions Studied
Interventions
- DRUG Zirgan
- DRUG genteal gel
Study Locations (1)
Missouri
- Lifelong Vision Foundation - Chesterfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01533480
The ClinicalTrials.gov registry entry for NCT01533480 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lifelong Vision Foundation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Keratoconjunctivitis Due to Adenovirus appearing as the primary indexed condition, and to 2 interventions - of which Zirgan is the first listed.
NCT01533480 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT01533480 about?
NCT01533480 is a clinical study titled "A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis". The investigators are conducting this study because the patient have an eye infection which is called adenoviral conjunctivitis, and is the most common cause of "pink eye". There is currently no treatment for this condition. However, the researchers associated with this study want to understand if u...
What is the current status of trial NCT01533480?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2012-01. Estimated completion is 2016-04.
What conditions does trial NCT01533480 study?
This clinical trial studies the following conditions: Keratoconjunctivitis Due to Adenovirus, Viral Shedding.
What interventions are being tested in trial NCT01533480?
The interventions under investigation include: Zirgan (DRUG), genteal gel (DRUG).
Who is sponsoring clinical trial NCT01533480?
This trial is sponsored by Lifelong Vision Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01533480 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.